Your browser doesn't support javascript.
loading
Management and characteristics of patients suffering from Clostridiodes difficile infection in primary care.
Klezovich-Bénard, Maria; Bouchand, Frédérique; Rouveix, Elisabeth; Goossens, Pierre L; Davido, Benjamin.
Afiliação
  • Klezovich-Bénard M; Département de Médecine Générale, l'Université de Versailles Saint Quentin en Yvelines, France.
  • Bouchand F; Pharmacie Hospitalière, Centre Hospitalier Universitaire Raymond Poincaré, AP-HP, Garches, France.
  • Rouveix E; Service des Maladies Infectieuses, Centre Hospitalier Universitaire Raymond Poincaré, AP-HP, Garches, France.
  • Goossens PL; Yersinia Research Unit, Institut Pasteur, Paris, France.
  • Davido B; Service des Maladies Infectieuses, Centre Hospitalier Universitaire Raymond Poincaré, AP-HP, Garches, France.
Eur J Gen Pract ; 27(1): 320-325, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34755587
ABSTRACT

BACKGROUND:

Clostridioides difficile infection (CDI) is rising and increases patient healthcare costs due to extended hospitalisation, tests and medications. Management of CDI in French primary care is poorly reported.

OBJECTIVES:

To characterise patients suffering from CDI, managed in primary care and describe their clinical outcomes.

METHODS:

Retrospective observational study based on survey data among 500 randomly selected General Practitioners (GPs) surveyed in France from September 2018 to April 2019. GPs were asked to complete a multiple-choice questionnaire for each reported patient presenting a CDI. Responses were analysed according to clinical characteristics. Treatment strategies were compared according to the

outcome:

recovery or recurrent infection.

RESULTS:

Participation rate was 8.6% (n = 43/500) with two incomplete questionnaires. Data from 41 patients with an actual diagnosis of CDI were analysed. Recovery was observed in 61% of patients with a confirmed diagnosis of CDI. In the recovery group, this was exclusively a primary episode, most patients (72%) had no comorbidities, were significantly younger (p = 0.02) than the ones who relapsed and 92% were successfully treated with oral metronidazole. Duration of diarrhoea after antimicrobial treatment initiation was significantly shorter in the recovery group (≤ 48 h) (p = 0.03). Cooperation with hospital specialists was reported in 28% of the recovery group versus 87.5% of the recurrent group (p = 0.0003). Overall, GPs managed successfully 82.9% of cases without need of hospital admission.

CONCLUSION:

GPs provide relevant ambulatory care for mild primary episodes of CDI using oral metronidazole. Persistent diarrhoea despite an appropriate anti-Clostridiodes regimen should be interpreted as an early predictor of relapse.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Clostridioides difficile / Infecções por Clostridium Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Gen Pract Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Clostridioides difficile / Infecções por Clostridium Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Gen Pract Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França